Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice
Abstract Optimizing intratumoral dendritic cell (DC)-T cell responses is pivotal for effective cancer immunotherapy. However, the mechanistic governing these dynamics within the tumor microenvironment (TME) remains unclear, and strategies to improve their therapeutic potential are underexplored. Her...
Saved in:
| Main Authors: | Xiaozhe Yin, Zexuan Ding, Li Yu, Xuhao Zhang, Yu Gao, Yiyan Li, Zhibo Liu, Yang-Xin Fu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60769-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single atom engineering for radiotherapy-activated immune agonist prodrugs
by: Zexuan Ding, et al.
Published: (2025-07-01) -
Perspective to clinical translation of radiotherapy-activated prodrugs: challenges and advances
by: Qiang Wei, et al.
Published: (2025-06-01) -
Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate Cancer
by: Seyedeh A. Najibi, et al.
Published: (2025-05-01) -
A Novel Application Paradigm for Tumor In-Situ Vaccination: Synergistic Effects of TLR7/8 Agonists and Radiotherapy
by: Xiaolin YOU, et al.
Published: (2025-07-01) -
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer
by: Ping Jin, et al.
Published: (2025-04-01)